Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy

This study has been completed.

Sponsor:

Collaborator:

Canadian Institutes of Health Research (CIHR)

Information provided by (Responsible Party):

University of Ottawa Heart Institute

ClinicalTrials.gov Identifier:

NCT00247975

First received: October 31, 2005

Last updated: February 6, 2012

Last verified: February 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2011
Primary Completion Date:	October 2010 (Final data collection date for primary outcome measure)